Quick Answer
BioCorRx Inc. reported Net Income Loss of -$3.44 million for the year ending 2025.
- BioCorRx Inc. showed an increase of +32.6% in Net Income Loss from 2024 to 2025.
- This data is from BioCorRx Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), BioCorRx Inc.'s Net Income Loss has declined by 2,125.3%.
- Historical annual values: Fiscal year 2025: -$3.44 million | Fiscal year 2024: -$5.11 million | Fiscal year 2023: -$3.77 million | Fiscal year 2022: -$4.38 million | Fiscal year 2021: -$5.21 million | Fiscal year 2020: -$3.51 million | Fiscal year 2019: -$6.05 million | Fiscal year 2018: -$6.58 million | Fiscal year 2017: -$29.71 million | Fiscal year 2016: -$5.90 million | Fiscal year 2015: -$4.67 million | Fiscal year 2014: -$3.13 million | Fiscal year 2013: -$3.84 million | Fiscal year 2012: -$885.8 thousand | Fiscal year 2011: -$409.0 thousand | Fiscal year 2010: -$154.6 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: